Company profile: VerAvanti
1.1 - Company Overview
Company description
- Provider of single-use intravascular endoscopic technologies, including a Scanning Fiber Endoscope delivering real-time, high-resolution images of intravascular anatomy to help diagnose and treat stroke and cardiovascular events; in-house MEMS manufacturing of micro-small components using precise robotics and cleanroom assembly; and O-pH imaging to measure oral biofilm acidity to predict and manage tooth decay.
Products and services
- MEMS Manufacturing: In-house facility fabricates micro-scale SFE components using precise robotics and cleanroom assembly, delivering cleanroom-assembled reliability for consistent intravascular imaging performance
- O-pH Imaging: Enamel-targeted system measures oral biofilm acidity to identify high-risk enamel zones, enabling prediction and management of tooth decay across patient-specific sites
- Scanning Fiber Endoscope (SFE): Single-use, intravascular endoscopic device produces real-time, high-resolution images of vascular anatomy to assist diagnosis and treatment of stroke and cardiovascular events
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VerAvanti
Intelesens
HQ: United Kingdom
Website
- Description: Provider of intelligent, wearable, non-invasive, wireless vital signs monitoring devices for hospital and home patient monitoring, leveraging proprietary high-sensitivity arrhythmia and respiratory algorithms, and offering defibrillation and ECG electrodes plus custom electrode design, prototyping, and end-to-end manufacturing compliant with international regulatory standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelesens company profile →
Longeveron
HQ: United States
Website
- Description: Provider of cellular therapies and research programs, developing Lomecel-B, a culture-expanded medicinal signaling cell (MSC) therapy for aging-related diseases, Alzheimer’s disease, and hypoplastic left heart syndrome (HLHS), with programs testing its use in aging frailty, metabolic syndrome, and acute respiratory distress syndrome (ARDS) due to COVID-19 or influenza.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longeveron company profile →
Semler Scientific
HQ: United States
Website
- Description: Provider of medical risk-assessment solutions, including QuantaFlo software for non-invasive vascular disease risk assessment by evaluating extremity blood flow; SemlerShield for protection and security of medical data; SemlerVault for secure storage of sensitive medical information; SemlerAnalytics for insights and analytics on medical data; and SemlerSimulation, an online simulation-based training program for medical professionals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Semler Scientific company profile →
NovaCardia
HQ: United States
Website
- Description: Provider of cardiovascular drug development and commercialization of novel small molecule drugs to improve care for patients with cardiovascular disease; a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NovaCardia company profile →
ivWatch
HQ: United States
Website
- Description: Provider of intravenous infiltration detection solutions, including the ivWatch Monitoring System that continuously monitors peripheral IVs to detect infiltrations and extravasations early with real-time notifications to clinicians; SmartTouch single-use sensor and reusable optical fiber sensor for flexible, comfortable, MRI-compatible IV site monitoring; and OEM solutions to embed the technology into patient monitors or infusion pumps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ivWatch company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VerAvanti
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VerAvanti
2.2 - Growth funds investing in similar companies to VerAvanti
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VerAvanti
4.2 - Public trading comparable groups for VerAvanti
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →